CORRELATION BETWEEN LONG NON-CODING RNA H19 AND CANCER PLATINUM-BASED CHEMOTHERAPEUTIC DRUG RESISTANCE

• 1. 长非编码RNA H19与癌症铂类化疗药物耐药相关性 [P] . 中国专利： CN105126120B . 2018.12.21
• 2. 长非编码RNA H19与癌症铂类化疗药物耐药相关性 [P] . 中国专利： CN105126120A . 2015-12-09
• 3. PREPARATION AND APPLICATION OF AMPHIPHILIC DRUG-DRUG NANOPARTICLE FOR REVERSING PLATINUM-BASED ANTICANCER DRUG RESISTANCE IN CANCER THERAPY [P] . 世界知识产权组织专利： WO2018133687A1 . 2018-07-26

  机译： 逆转铂基抗癌药耐药性的两用药物纳米颗粒的制备及应用

• 4. CANCER TREATMENT AND ASSAYS FOR DETERMIMING RESISTANCE TO PLATINUM-BASED CHEMOTHERAPEUTIC AGENT [P] . 欧洲知识产权局专利： EP1723259A2 . 2006-11-22

  机译： 癌症治疗和对铂类化疗药物耐药性的测定

• 5. CANCER TREATMENT AND ASSAYS FOR DETERMINING RESISTANCE TO PLATINUM-BASED CHEMOTHERAPEUTIC AGENT [P] . SG125509A1 . 2006-10-30

  机译： 确定针对铂类化学治疗剂的耐药性的癌症治疗和评估

• 1. A study on the relationship between long non-coding RNA H19 and high-grade glioma temozolomide resistance and their related mechanism [J] . Peng-Xiang Xu, Qiang Li, Qiong-Guan Xu, 海南医科大学学报（英文版） . 2017,第012期
• 2. A study on the relationship between long non-coding RNA H19 and high-grade glioma temozolomide resistance and their related mechanism [J] . Peng-Xiang Xu, Qiang Li, Qiong-Guan Xu, 海南医科大学学报(英文版) . 2017,第012期
• 3. Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer [J] . Zhigang Sun, Chi Zhang, Tiantian Wang, Journal of Cancer Research and Therapeutics . 2019,第4期
• 4. Polymorphisms in IGF2/H19 gene locus are associated with platinum-based chemotherapeutic response in Chinese patients with epithelial ovarian cancer [J] . Zeng Ying, Li Tai-Lin, Zhang Hai-Bo, Pharmacogenomics . 2019,第3期
• 5. Correlation of a Long Non-Coding RNA, H19, With Metastasis of Pancreatic Cancer [J] . Ishiwata T., Yoshimura H., Matsuda Y., Pancreas . 2016,第10期
• 6. W/o/w Emulsion for Cancer Therapy: the New Delivery Way to Increase Platinum-based Anticancer Drugs' Activity [C] . Kong Feng, Lv Jingbo 第三届国际贵金属会议（The Third International Conference on Precious Metals）论文集 . 2008
• 7. Towards enhanced cancer chemotherapy: Studies on drug design, synergy, and drug target expression and resistance with the combretastatins and other chemotherapeutics. [D] . Wehbe, Hania. 2005
• 8. Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma [O] . Qi Wang, Ningning Cheng, Xuefei Li, 2017
• 9. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response [O] . Burger H. (Herman), Foekens J.A. (John), Look M.P. (Maxime), 2003
• 10. Collagen VI: A New Candidate Breast Cancer Marker Linked to Resistance to Platinum-Based Cancer Drugs. [R] . Park, J. 2012

• 1. Non-coding RNA in drug resistance of gastric cancer [J] . Ya-Jun Luo ,Qing-Mei Huang ,Yan Ren . 世界胃肠肿瘤学杂志：英文版（电子版） . 2019,第11期
• 2. Transduction of Fas gene or Bcl-2 antisense RNA sensitizes cultured drug resistant gastric cancer cells to chemotherapeutic drugs [J] . XIAO Bing SHI Yong Quan ZHAO Yan Qiu YOU Han WANG Zuo You LIU Xian Ling YIN Fang QIAO Tai Dong and FAN Dai Ming . 世界胃肠病学杂志：英文版 . 1998,第5期
• 3. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of micro RNA-137 [J] . Jing Liang ,Xiao-Feng Tian ,Wei Yang . 世界胃肠病学杂志：英文版 . 2020,第13期
• 4. 外用中药对铂类化疗药物神经毒性的治疗研究 [C] . 司马蕾 ,贾立群 ,于莉莉 . 中国老年肿瘤学大会暨第二届CGOS学术年会 . 2007
• 5. eIF3a和CTR1基因变异与肺癌患者铂类化疗药物反应差异及预后的相关性研究 [A] . 徐潇静 . 2013